Company

Kinea Bio

Biotechnology Research The Most Critical Challenges Facing the Field of Gene Therapy 6 employees

Employees: 6
Contacts: 1
Emails: 1

www.kineabio.com LinkedIn Crunchbase

Kinea Bio Overview

Headquarters: The Most Critical Challenges Facing the Field of Gene Therapy
Website: www.kineabio.com
Industry: Biotechnology Research
Employees: 6
Funding: 500.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

biotechnology

About Kinea Bio

Kinea Bio is a patient-focused biotechnology company striving to accelerate the development of next-generation AAV-based gene therapies to treat neuromuscular diseases. Kinea is developing an integrated technology platform designed to address the most critical challenges facing the field of gene therapy, including novel targeting and gene regulation technologies, advanced engineered tissue modeling capabilities, and strategies that will enable delivery of larger, more functional therapeutic cargos that has previously been possible.

Kinea Bio Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Kinea Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nicholas Wageling, Phd	Director of Operations at Kinea Bio	Tacoma, Washington, United States	View
Martin K. (Casey) Childers Do, Phd	Co-founder and Chief Executive Officer	Seattle, Washington, United States	Email
Taylor Chen	Director of Process Development - Kinea	Belchertown, Massachusetts, United States	View